» Articles » PMID: 1908219

Characterization of the Solubilized Glibenclamide Receptor in a Hamster Pancreatic Beta-cell Line, HIT T15

Overview
Journal Biochem J
Specialty Biochemistry
Date 1991 Aug 1
PMID 1908219
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The glibenclamide receptor, a putative ATP-sensitive K+ channel in the hamster pancreatic beta-cell line HIT T15, was solubilized by using the zwitterionic detergent CHAPS. [3H]Glibenclamide binding was dependent on the incubation time and on the concentration of soluble membrane protein. Over 80% of [3H]glibenclamide bound could be displaced with 1 microM non-labelled glibenclamide. The curve relating specific binding to the concentration of [3H]glibenclamide (1-20 nM) showed saturation kinetics. Scatchard analysis suggested a single class of non-interacting binding sites with a Kd of 3.3 nM and a Bmax. of 90 fmol/mg of protein. [3H]Glibenclamide binding to solubilized membranes was inhibited by glibenclamide, tolbutamide and meglitinide. The relative potency of these agents on binding of [3H]glibenclamide to solubilized membranes was similar to that observed with microsomal preparations and paralleled their effects on K-ATP channel activity, measured as 86Rb efflux. These data show that the sulphonylurea receptor in the pancreatic beta-cell can be solubilized in an active form retaining specificity for sulphonylureas. ADP, which inhibits [3H]glibenclamide binding to microsomal preparations or intact HIT beta-cells, did not inhibit binding to the solubilized receptor. Incubation of intact HIT beta-cells with 125I-glibenclamide derivative followed by exposure to u.v. light resulted in covalent labelling of a peptide of 65 kDa on SDS/PAGE. The extent of labelling increased with 125I-glibenclamide derivative concentration (1-20 nM) and was inhibited in the presence of excess unlabelled glibenclamide.

Citing Articles

The short form of the SUR1 and its functional implications in the damaged brain.

Alquisiras-Burgos I, Franco-Perez J, Rubio-Osornio M, Aguilera P Neural Regen Res. 2021; 17(3):488-496.

PMID: 34380876 PMC: 8504400. DOI: 10.4103/1673-5374.320967.


Coexistence of two classes of glibenclamide-inhibitable ATP-regulated K+ channels in avian skeletal muscle.

Fosset M, Allard B, Lazdunski M Pflugers Arch. 1995; 431(1):117-24.

PMID: 8584408 DOI: 10.1007/BF00374384.

References
1.
Geisen K, Hitzel V, Okomonopoulos R, Punter J, Weyer R, SUMM H . Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics. Arzneimittelforschung. 1985; 35(4):707-12. View

2.
Garrino M, Schmeer W, Nenquin M, MEISSNER H, Henquin J . Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia. 1985; 28(9):697-703. DOI: 10.1007/BF00291979. View

3.
Niki I, Nicks J, Ashcroft S . The beta-cell glibenclamide receptor is an ADP-binding protein. Biochem J. 1990; 268(3):713-8. PMC: 1131498. DOI: 10.1042/bj2680713. View

4.
Aguilar-Bryan L, Nelson D, Vu Q, Humphrey M, Boyd 3rd A . Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog. J Biol Chem. 1990; 265(14):8218-24. View

5.
Noma A . ATP-regulated K+ channels in cardiac muscle. Nature. 1983; 305(5930):147-8. DOI: 10.1038/305147a0. View